Drugs

Department of Health written question – answered on 3rd July 2015.

Alert me about debates like this

Photo of Grahame Morris Grahame Morris Labour, Easington

To ask the Secretary of State for Health, what role is played by NHS England in deciding on the cost-effectiveness of new drug treatments.

Photo of George Freeman George Freeman The Parliamentary Under-Secretary of State for Business, Innovation and Skills, The Parliamentary Under-Secretary of State for Health

The National Institute for Health and Care Excellence (NICE) is the independent body that advises the National Health Service on the clinical and cost effectiveness of selected new drugs and treatments.

In the absence of guidance from NICE, or where negative guidance has been issued, it is for commissioners, including NHS England in respect of its directly commissioned services, to make funding decisions based on the available evidence.

Does this answer the above question?

Yes0 people think so

No1 person thinks not

Would you like to ask a question like this yourself? Use our Freedom of Information site.